Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 01, 2015 5:40 PM ET

Pharmaceuticals

Company Overview of Shilpa Medicare Limited

Company Overview

Shilpa Medicare Limited manufactures and sells bulk drugs in India. It offers active pharmaceutical ingredients, intermediates (APIs), formulations, drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company provides its APIs, intermediates, and formulations in the therapeutic areas of oncology, anti-retroviral, multiple sclerosis, immunosuppressant therapies, etc. Shilpa Medicare Limited also exports its products to the United States, Canada, Australia, and Japan; European countries, such as Germany, Switzerland, the Netherlands, Belgium, Spain, Greece, Cyprus, Italy, the United Kingdom, etc.; South American countries, including Mexico, Brazil, Columbia, etc.; A...

10/80, Rajendra Gunj

1st Floor

Raichur,  584102

India

Founded in 1987

Phone:

91 85 3223 6494

Fax:

91 85 3223 5876

Key Executives for Shilpa Medicare Limited

Shilpa Medicare Limited does not have any Key Executives recorded.

Shilpa Medicare Limited Key Developments

Shilpa Medicare Limited Appoints Namrata Bhutada as Additional Director

Shilpa Medicare Limited has announced that Ms. Namrata Bhutada has been co-opted as Additional Director, effective February 28, 2015 by the Board of Directors of the company.

Shilpa Medicare Limited Reports Unaudited Consolidated and Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Shilpa Medicare Limited reported unaudited consolidated and standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, standalone total income from operations was INR 1,452.181 million, profit from operations before other income, finance costs and exceptional items was INR 309.980 million, profit from ordinary activates before tax was INR 308.402 million and net profit was INR 195.165 million or INR 5.10 per basic and diluted after extraordinary items (not annualized) against total income from operations was INR 1,404.628 million, profit from operations before other income, finance costs and exceptional items was INR 284.137 million, profit from ordinary activates before tax was INR 287.378 million and net profit was INR 230.820 million or INR 6.27 per basic and diluted after extraordinary items (not annualized) a year ago. For the quarter, consolidated total income from operations was INR 1,545.021 million, profit from operations before other income, finance costs and exceptional items was INR 282.860 million, profit from ordinary activates before tax was INR 280.645 million and net profit was INR 168.107 million or INR 4.42 per basic and diluted after extraordinary items (not annualized) against total income from operations was INR 1,543.404 million, profit from operations before other income, finance costs and exceptional items was INR 291.889 million, profit from ordinary activates before tax was INR 290.305 million and net profit was INR 203.548 million or INR 5.62 per basic and diluted after extraordinary items (not annualized) a year ago. For the nine month period, standalone total income from operations was INR 4,152.990 million, profit from operations before other income, finance costs and exceptional items was INR 837.587 million, profit from ordinary activates before tax was INR 851.544 million, net profit was INR 606.386 million or INR 15.85 per basic and diluted after extraordinary items (not annualized) against total income from operations was INR 3,709.914 million, profit from operations before other income, finance costs and exceptional items was INR 666.633 million, profit from ordinary activates before tax was INR 715.206 million, net profit was INR 575.513 million or INR 15.64 per basic and diluted after extraordinary items (not annualized) a year ago. For the nine month period, consolidated total income from operations was INR 4,470.665 million, profit from operations before other income, finance costs and exceptional items was INR 748.548 million, profit from ordinary activates before tax was INR 757.546 million, net profit was INR 507.559 million or INR 13.40 per basic and diluted after extraordinary items (not annualized) against total income from operations was INR 4,039.310 million, profit from operations before other income, finance costs and exceptional items was INR 632.649 million, profit from ordinary activates before tax was INR 671.770 million, net profit was INR 502.718 million or INR 13.85 per basic and diluted after extraordinary items (not annualized) a year ago.

Shilpa Medicare Limited to Report Q3, 2015 Results on Feb 14, 2015

Shilpa Medicare Limited announced that they will report Q3, 2015 results on Feb 14, 2015

Similar Private Companies By Industry

Company Name Region
Lyka BDR International Ltd. Asia
Jubilant Innovation (India) Ltd. Asia
MJ Pharmaceuticals Ltd. Asia
Parke-Davis Ltd. Asia
Grandix Pharmaceuticals, Ltd. Asia

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 30, 2015
--
Private Placement
April 11, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shilpa Medicare Limited, please visit www.vbshilpa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.